ACSI vs. FPXE ETF Comparison
Comparison of American Customer Satisfaction Core Alpha ETF (ACSI) to First Trust IPOX Europe Equity Opportunities ETF (FPXE)
ACSI
American Customer Satisfaction Core Alpha ETF
ACSI Description
American Customer Satisfaction Core Alpha ETF (the %u201CFund%u201D) seeks to track the performance, before fees and expenses, of the American Customer Satisfaction Investable Index (the %u201CIndex%u201D).
Grade (RS Rating)
Last Trade
$51.01
Average Daily Volume
240
Number of Holdings
*
33
* may have additional holdings in another (foreign) market
FPXE
First Trust IPOX Europe Equity Opportunities ETF
FPXE Description
The First Trust IPOX® Europe Equity Opportunities ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the IPOX® 100 Europe Index (the "Index"). The Fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks and/or depositary receipts that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Fund's investment advisor seeks a correlation of 0.95 or better (before fees and expenses) between the Fund's performance and the performance of the Index; a figure of 1.00 would represent perfect correlation. The Index is owned, developed, maintained and sponsored by IPOX® Schuster LLC (the "Index Provider").Grade (RS Rating)
Last Trade
$24.12
Average Daily Volume
258
Number of Holdings
*
23
* may have additional holdings in another (foreign) market
Performance
Period | ACSI | FPXE |
---|---|---|
30 Days | -1.68% | -4.76% |
60 Days | 1.15% | -3.49% |
90 Days | 3.57% | 6.79% |
12 Months | 16.68% | 11.52% |
0 Overlapping Holdings
Symbol | Grade | Weight in ACSI | Weight in FPXE | Overlap |
---|
ACSI Overweight 33 Positions Relative to FPXE
Symbol | Grade | Weight | |
---|---|---|---|
AAPL | F | 7.91% | |
COST | C | 5.79% | |
GOOG | A | 5.53% | |
AMZN | C | 5.16% | |
MSFT | C | 5.08% | |
JPM | B | 4.31% | |
KDP | A | 3.98% | |
UNH | D | 3.49% | |
HUM | F | 3.37% | |
AIG | B | 3.25% | |
ALK | B | 3.1% | |
FDX | B | 2.85% | |
MSI | B | 2.64% | |
TMUS | A | 2.56% | |
LEVI | A | 2.5% | |
TXRH | A | 2.46% | |
YUM | A | 2.46% | |
TSCO | A | 2.42% | |
PINS | C | 2.42% | |
SKX | A | 2.41% | |
T | B | 2.37% | |
ORLY | D | 2.36% | |
SCHW | A | 2.32% | |
VZ | C | 2.32% | |
MS | A | 2.24% | |
AEO | B | 2.22% | |
HLT | C | 2.22% | |
NFLX | D | 2.21% | |
TSLA | C | 2.08% | |
CLX | C | 1.92% | |
DUK | A | 1.31% | |
ATO | A | 1.3% | |
BRK.A | C | 1.25% |
ACSI Underweight 23 Positions Relative to FPXE
Symbol | Grade | Weight | |
---|---|---|---|
NVT | B | -8.55% | |
ARM | D | -5.0% | |
SPOT | B | -3.57% | |
MNDY | C | -2.64% | |
ONON | D | -2.0% | |
HAFN | B | -1.9% | |
ICLR | D | -1.54% | |
CLBT | C | -1.05% | |
BIRK | D | -0.84% | |
ZGN | D | -0.44% | |
FROG | C | -0.43% | |
STVN | D | -0.36% | |
PHVS | B | -0.29% | |
JHG | C | -0.25% | |
CNTA | D | -0.22% | |
IMCR | D | -0.14% | |
CMPS | C | -0.13% | |
MRUS | C | -0.13% | |
PAX | D | -0.1% | |
SPNT | C | -0.1% | |
VTEX | D | -0.07% | |
OSW | C | -0.06% | |
IMTX | F | -0.05% |
ACSI: Top Represented Industries & Keywords
Industries:
Specialty Retail
Telecom Services
Capital Markets
Health Care Plans
Insurance - Diversified
Internet Content & Information
Restaurants
Airlines
Apparel Manufacturing
Apparel Stores
Auto Manufacturers
Banks - Global
Beverages - Soft Drinks
Communication Equipment
Consumer Electronics
Discount Stores
Footwear & Accessories
Household & Personal Products
Integrated Shipping & Logistics
Lodging
FPXE: Top Represented Industries & Keywords
Industries:
Biotechnology
Software - Application
Asset Management
Apparel Manufacturing
Apparel Retail
Diagnostics & Research
Electronic Components
Footwear & Accessories
Insurance - Reinsurance
Internet Content & Information
Leisure
Medical Care Facilities
Medical Instruments & Supplies
Semiconductors
Software - Infrastructure
Keywords:
Medicine
Biotechnology
Cancer
Immunotherapy
Shoe
Actuarial Science
Biopharmaceutical
Clinical Medicine
Footwear
Health Sciences
IBD 50
Immunotherapies
Retail Store
Software
Solid Tumors
Virotherapy
Acute Myeloid Leukemia
Adoptive Cell Transfer
Agile Software Development
Alpha 1 Antitrypsin